ZA200404919B - Effectors of innate immunity - Google Patents

Info

Publication number

ZA200404919B

ZA200404919B ZA200404919A ZA200404919A ZA200404919B ZA 200404919 B ZA200404919 B ZA 200404919B ZA 200404919 A ZA200404919 A ZA 200404919A ZA 200404919 A ZA200404919 A ZA 200404919A ZA 200404919 B ZA200404919 B ZA 200404919B

Authority

ZA

South Africa

Prior art keywords

peptide

seq

expression

polynucleotide

protein

Prior art date

2001-12-03

Links

• Espacenet
• Global Dossier
• Discuss

• 230000015788 innate immune response Effects 0.000 title claims description 49
• 239000012636 effector Substances 0.000 title description 5
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 424
• 108091033319 polynucleotide Proteins 0.000 claims description 266
• 102000040430 polynucleotide Human genes 0.000 claims description 266
• 239000002157 polynucleotide Substances 0.000 claims description 260
• 210000004027 cell Anatomy 0.000 claims description 174
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 164
• 230000014509 gene expression Effects 0.000 claims description 155
• 125000002091 cationic group Chemical group 0.000 claims description 144
• 238000000034 method Methods 0.000 claims description 97
• 108090000623 proteins and genes Proteins 0.000 claims description 78
• 239000003795 chemical substances by application Substances 0.000 claims description 66
• 150000001875 compounds Chemical class 0.000 claims description 64
• 102100040247 Tumor necrosis factor Human genes 0.000 claims description 50
• 102000004169 proteins and genes Human genes 0.000 claims description 49
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 48
• 230000001105 regulatory effect Effects 0.000 claims description 48
• 150000001413 amino acids Chemical class 0.000 claims description 47
• 206010040047 Sepsis Diseases 0.000 claims description 45
• 102000005962 receptors Human genes 0.000 claims description 43
• 108020003175 receptors Proteins 0.000 claims description 42
• 230000004044 response Effects 0.000 claims description 39
• 230000000694 effects Effects 0.000 claims description 37
• 150000007523 nucleic acids Chemical class 0.000 claims description 35
• 102000039446 nucleic acids Human genes 0.000 claims description 34
• 108020004707 nucleic acids Proteins 0.000 claims description 34
• 230000001939 inductive effect Effects 0.000 claims description 33
• 230000002757 inflammatory effect Effects 0.000 claims description 28
• 230000003110 anti-inflammatory effect Effects 0.000 claims description 27
• 108020004414 DNA Proteins 0.000 claims description 26
• 208000015181 infectious disease Diseases 0.000 claims description 26
• 102000019034 Chemokines Human genes 0.000 claims description 24
• 108010012236 Chemokines Proteins 0.000 claims description 24
• 230000001580 bacterial effect Effects 0.000 claims description 24
• 229920001184 polypeptide Polymers 0.000 claims description 22
• 230000000770 proinflammatory effect Effects 0.000 claims description 20
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 16
• 241000894006 Bacteria Species 0.000 claims description 15
• 102000004890 Interleukin-8 Human genes 0.000 claims description 15
• 108090001007 Interleukin-8 Proteins 0.000 claims description 15
• 230000005764 inhibitory process Effects 0.000 claims description 15
• 238000012360 testing method Methods 0.000 claims description 15
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 14
• 230000000638 stimulation Effects 0.000 claims description 14
• 229910052717 sulfur Inorganic materials 0.000 claims description 14
• 102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 14
• 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 claims description 13
• 206010061218 Inflammation Diseases 0.000 claims description 13
• 230000004054 inflammatory process Effects 0.000 claims description 13
• -1 CCRS5 Proteins 0.000 claims description 12
• 239000005557 antagonist Substances 0.000 claims description 12
• 230000008859 change Effects 0.000 claims description 11
• 108091000080 Phosphotransferase Proteins 0.000 claims description 10
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims description 10
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims description 10
• 230000003260 anti-sepsis Effects 0.000 claims description 10
• 238000006243 chemical reaction Methods 0.000 claims description 10
• 102000020233 phosphotransferase Human genes 0.000 claims description 10
• 230000007423 decrease Effects 0.000 claims description 9
• 108010055166 Chemokine CCL5 Proteins 0.000 claims description 8
• 230000035605 chemotaxis Effects 0.000 claims description 8
• 229910052700 potassium Inorganic materials 0.000 claims description 8
• 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 7
• 101710155857 C-C motif chemokine 2 Proteins 0.000 claims description 7
• 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 7
• 102000015696 Interleukins Human genes 0.000 claims description 7
• 108010063738 Interleukins Proteins 0.000 claims description 7
• 239000000954 inflammatory inducer Substances 0.000 claims description 7
• 230000028709 inflammatory response Effects 0.000 claims description 7
• 102100032366 C-C motif chemokine 7 Human genes 0.000 claims description 6
• 101710155834 C-C motif chemokine 7 Proteins 0.000 claims description 6
• 102000009410 Chemokine receptor Human genes 0.000 claims description 6
• 108050000299 Chemokine receptor Proteins 0.000 claims description 6
• 102000003814 Interleukin-10 Human genes 0.000 claims description 6
• 108090000174 Interleukin-10 Proteins 0.000 claims description 6
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 6
• 229910052731 fluorine Inorganic materials 0.000 claims description 6
• 239000000816 peptidomimetic Substances 0.000 claims description 6
• 229910052727 yttrium Inorganic materials 0.000 claims description 6
• 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 claims description 5
• 102100032710 E3 ubiquitin-protein ligase Jade-2 Human genes 0.000 claims description 5
• 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 claims description 5
• 101000994468 Homo sapiens E3 ubiquitin-protein ligase Jade-2 Proteins 0.000 claims description 5
• 102000014150 Interferons Human genes 0.000 claims description 5
• 108010050904 Interferons Proteins 0.000 claims description 5
• 241000700605 Viruses Species 0.000 claims description 5
• 229910052698 phosphorus Inorganic materials 0.000 claims description 5
• 229910052721 tungsten Inorganic materials 0.000 claims description 5
• 101000665837 Homo sapiens Protein Red Proteins 0.000 claims description 4
• 102100035678 Interferon gamma receptor 1 Human genes 0.000 claims description 4
• 102100038276 Protein Red Human genes 0.000 claims description 4
• 108091023040 Transcription factor Proteins 0.000 claims description 4
• 102000040945 Transcription factor Human genes 0.000 claims description 4
• 230000036039 immunity Effects 0.000 claims description 4
• 102000006495 integrins Human genes 0.000 claims description 4
• 108010044426 integrins Proteins 0.000 claims description 4
• DAZSWUUAFHBCGE-KRWDZBQOSA-N n-[(2s)-3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-yl]-3-phenylpropanamide Chemical compound N([C@@H](C(C)C)C(=O)N1CCCC1)C(=O)CCC1=CC=CC=C1 DAZSWUUAFHBCGE-KRWDZBQOSA-N 0.000 claims description 4
• 102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims description 3
• 101710149815 C-C chemokine receptor type 2 Proteins 0.000 claims description 3
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims description 3
• 101710112613 C-C motif chemokine 13 Proteins 0.000 claims description 3
• 102100023702 C-C motif chemokine 13 Human genes 0.000 claims description 3
• 101710155833 C-C motif chemokine 8 Proteins 0.000 claims description 3
• 102100034871 C-C motif chemokine 8 Human genes 0.000 claims description 3
• 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 claims description 3
• 108010017009 CD11b Antigen Proteins 0.000 claims description 3
• 102000004354 CD11b Antigen Human genes 0.000 claims description 3
• 108090000613 Cathepsin S Proteins 0.000 claims description 3
• 102100035654 Cathepsin S Human genes 0.000 claims description 3
• 102000000844 Cell Surface Receptors Human genes 0.000 claims description 3
• 108010001857 Cell Surface Receptors Proteins 0.000 claims description 3
• 102100023309 Centrosomal protein of 152 kDa Human genes 0.000 claims description 3
• 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 claims description 3
• 101710194728 Cytokine receptor-like factor 1 Proteins 0.000 claims description 3
• 241000233866 Fungi Species 0.000 claims description 3
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 3
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 3
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims description 3
• 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 claims description 3
• 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 3
• 101000908174 Homo sapiens Centrosomal protein of 152 kDa Proteins 0.000 claims description 3
• 101000701393 Homo sapiens Serine/threonine-protein kinase 26 Proteins 0.000 claims description 3
• 101000595531 Homo sapiens Serine/threonine-protein kinase pim-1 Proteins 0.000 claims description 3
• 101710174028 Interferon gamma receptor 1 Proteins 0.000 claims description 3
• 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 claims description 3
• 108010063954 Mucins Proteins 0.000 claims description 3
• 101000978374 Mus musculus C-C motif chemokine 12 Proteins 0.000 claims description 3
• 108010064527 OSM-LIF Receptors Proteins 0.000 claims description 3
• 101710094502 Proteasome subunit beta type-5 Proteins 0.000 claims description 3
• 102100036127 Proteasome subunit beta type-5 Human genes 0.000 claims description 3
• 102100030617 Serine/threonine-protein kinase 26 Human genes 0.000 claims description 3
• 102100036077 Serine/threonine-protein kinase pim-1 Human genes 0.000 claims description 3
• 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 claims description 3
• 101710187885 Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 claims description 3
• 102000003675 cytokine receptors Human genes 0.000 claims description 3
• 108010057085 cytokine receptors Proteins 0.000 claims description 3
• 230000002708 enhancing effect Effects 0.000 claims description 3
• 230000002209 hydrophobic effect Effects 0.000 claims description 3
• 229940079322 interferon Drugs 0.000 claims description 3
• 108010085650 interferon gamma receptor Proteins 0.000 claims description 3
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims description 3
• 210000002824 peroxisome Anatomy 0.000 claims description 3
• 230000002829 reductive effect Effects 0.000 claims description 3
• 108090000064 retinoic acid receptors Proteins 0.000 claims description 3
• 102000003702 retinoic acid receptors Human genes 0.000 claims description 3
• 108010041788 rho-Associated Kinases Proteins 0.000 claims description 3
• 102000000568 rho-Associated Kinases Human genes 0.000 claims description 3
• 238000012216 screening Methods 0.000 claims description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 2
• 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 2
• 102100036850 C-C motif chemokine 23 Human genes 0.000 claims description 2
• 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims description 2
• 102100023272 Dual specificity mitogen-activated protein kinase kinase 5 Human genes 0.000 claims description 2
• 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 claims description 2
• 102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 claims description 2
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims description 2
• 101001049692 Homo sapiens E3 SUMO-protein ligase EGR2 Proteins 0.000 claims description 2
• 101001098557 Homo sapiens Proteinase-activated receptor 3 Proteins 0.000 claims description 2
• 101000959153 Homo sapiens RNA demethylase ALKBH5 Proteins 0.000 claims description 2
• 102100036157 Interferon gamma receptor 2 Human genes 0.000 claims description 2
• 102000004551 Interleukin-10 Receptors Human genes 0.000 claims description 2
• 108010017550 Interleukin-10 Receptors Proteins 0.000 claims description 2
• 108010018951 Interleukin-8B Receptors Proteins 0.000 claims description 2
• 108010068305 MAP Kinase Kinase 5 Proteins 0.000 claims description 2
• 108010068306 MAP Kinase Kinase 6 Proteins 0.000 claims description 2
• 102100028397 MAP kinase-activated protein kinase 3 Human genes 0.000 claims description 2
• 101710141393 MAP kinase-activated protein kinase 3 Proteins 0.000 claims description 2
• 108700027650 Mitogen-Activated Protein Kinase 7 Proteins 0.000 claims description 2
• 102100026932 Mitogen-activated protein kinase 12 Human genes 0.000 claims description 2
• 108700015929 Mitogen-activated protein kinase 12 Proteins 0.000 claims description 2
• 102100037805 Mitogen-activated protein kinase 7 Human genes 0.000 claims description 2
• 102000006746 NADH Dehydrogenase Human genes 0.000 claims description 2
• 108010086428 NADH Dehydrogenase Proteins 0.000 claims description 2
• 102100037133 Proteinase-activated receptor 3 Human genes 0.000 claims description 2
• 102100033605 RING finger protein 10 Human genes 0.000 claims description 2
• 101710119956 RING finger protein 10 Proteins 0.000 claims description 2
• 102100039083 RNA demethylase ALKBH5 Human genes 0.000 claims description 2
• 229910052799 carbon Inorganic materials 0.000 claims description 2
• 102000033650 death receptor binding proteins Human genes 0.000 claims description 2
• 108091009627 death receptor binding proteins Proteins 0.000 claims description 2
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 229940047122 interleukins Drugs 0.000 claims description 2
• 230000003071 parasitic effect Effects 0.000 claims description 2
• 102000015278 OSM-LIF Receptors Human genes 0.000 claims 2
• 102000004357 Transferases Human genes 0.000 claims 2
• 108090000992 Transferases Proteins 0.000 claims 2
• 101710185494 Zinc finger protein Proteins 0.000 claims 2
• 102100023597 Zinc finger protein 816 Human genes 0.000 claims 2
• 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 1
• 101100502609 Caenorhabditis elegans fem-1 gene Proteins 0.000 claims 1
• 102100025705 Centrosomal protein of 170 kDa protein B Human genes 0.000 claims 1
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 claims 1
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 claims 1
• 101710088194 Dehydrogenase Proteins 0.000 claims 1
• 101100334582 Drosophila melanogaster Fem-1 gene Proteins 0.000 claims 1
• 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 claims 1
• 102100023275 Dual specificity mitogen-activated protein kinase kinase 3 Human genes 0.000 claims 1
• 102100029782 Eukaryotic translation initiation factor 3 subunit I Human genes 0.000 claims 1
• 101710109054 Eukaryotic translation initiation factor 3 subunit I Proteins 0.000 claims 1
• 108010049003 Fibrinogen Proteins 0.000 claims 1
• 102000008946 Fibrinogen Human genes 0.000 claims 1
• 102000004315 Forkhead Transcription Factors Human genes 0.000 claims 1
• 108090000852 Forkhead Transcription Factors Proteins 0.000 claims 1
• 101710117710 GTPase activating protein 1 Proteins 0.000 claims 1
• 102000009331 Homeodomain Proteins Human genes 0.000 claims 1
• 108010048671 Homeodomain Proteins Proteins 0.000 claims 1
• 101000983874 Homo sapiens Centrosomal protein of 170 kDa protein B Proteins 0.000 claims 1
• 101001006895 Homo sapiens Krueppel-like factor 11 Proteins 0.000 claims 1
• 101001069810 Homo sapiens Psoriasis susceptibility 1 candidate gene 2 protein Proteins 0.000 claims 1
• 102100027797 Krueppel-like factor 11 Human genes 0.000 claims 1
• 108010068342 MAP Kinase Kinase 1 Proteins 0.000 claims 1
• 108010068355 MAP Kinase Kinase 3 Proteins 0.000 claims 1
• 102000005879 Mucin-5B Human genes 0.000 claims 1
• 108010030201 Mucin-5B Proteins 0.000 claims 1
• 102000015728 Mucins Human genes 0.000 claims 1
• 102100034249 Psoriasis susceptibility 1 candidate gene 2 protein Human genes 0.000 claims 1
• 101710146873 Receptor-binding protein Proteins 0.000 claims 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 1
• 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims 1
• 108090000190 Thrombin Proteins 0.000 claims 1
• 230000000903 blocking effect Effects 0.000 claims 1
• 108700021031 cdc Genes Proteins 0.000 claims 1
• 230000024245 cell differentiation Effects 0.000 claims 1
• 230000004069 differentiation Effects 0.000 claims 1
• 239000003862 glucocorticoid Substances 0.000 claims 1
• 230000001629 suppression Effects 0.000 claims 1
• 229960004072 thrombin Drugs 0.000 claims 1
• 239000002158 endotoxin Substances 0.000 description 134
• 229920006008 lipopolysaccharide Polymers 0.000 description 122
• 241000282414 Homo sapiens Species 0.000 description 60
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 42
• 235000018102 proteins Nutrition 0.000 description 40
• 239000002299 complementary DNA Substances 0.000 description 34
• 235000001014 amino acid Nutrition 0.000 description 33
• 229940024606 amino acid Drugs 0.000 description 33
• 102000004127 Cytokines Human genes 0.000 description 30
• 108090000695 Cytokines Proteins 0.000 description 30
• 241000588724 Escherichia coli Species 0.000 description 29
• 210000002919 epithelial cell Anatomy 0.000 description 29
• 210000002540 macrophage Anatomy 0.000 description 28
• 238000004519 manufacturing process Methods 0.000 description 27
• 238000003491 array Methods 0.000 description 26
• 238000002474 experimental method Methods 0.000 description 22
• 241000699670 Mus sp. Species 0.000 description 19
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 18
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 17
• 238000011282 treatment Methods 0.000 description 17
• 244000052769 pathogen Species 0.000 description 15
• 238000002965 ELISA Methods 0.000 description 14
• 238000003556 assay Methods 0.000 description 14
• 239000000047 product Substances 0.000 description 14
• 239000000523 sample Substances 0.000 description 14
• 241000699666 Mus <mouse, genus> Species 0.000 description 13
• 230000006870 function Effects 0.000 description 13
• 210000004369 blood Anatomy 0.000 description 11
• 239000008280 blood Substances 0.000 description 11
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
• 239000002953 phosphate buffered saline Substances 0.000 description 11
• 239000011669 selenium Substances 0.000 description 10
• 238000011725 BALB/c mouse Methods 0.000 description 9
• 230000015572 biosynthetic process Effects 0.000 description 9
• 230000001965 increasing effect Effects 0.000 description 9
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 9
• 230000009467 reduction Effects 0.000 description 9
• 239000006228 supernatant Substances 0.000 description 9
• 108091006112 ATPases Proteins 0.000 description 8
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 8
• 239000002253 acid Substances 0.000 description 8
• 239000003242 anti bacterial agent Substances 0.000 description 8
• 239000000427 antigen Substances 0.000 description 8
• 108091007433 antigens Proteins 0.000 description 8
• 102000036639 antigens Human genes 0.000 description 8
• 230000034994 death Effects 0.000 description 8
• 231100000517 death Toxicity 0.000 description 8
• 239000007928 intraperitoneal injection Substances 0.000 description 8
• 231100000518 lethal Toxicity 0.000 description 8
• 230000001665 lethal effect Effects 0.000 description 8
• 210000000265 leukocyte Anatomy 0.000 description 8
• 230000004083 survival effect Effects 0.000 description 8
• 238000003786 synthesis reaction Methods 0.000 description 8
• 231100000419 toxicity Toxicity 0.000 description 8
• 230000001988 toxicity Effects 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
• 241001433703 Escherichia coli O111:B4 Species 0.000 description 7
• 239000004743 Polypropylene Substances 0.000 description 7
• 102000002689 Toll-like receptor Human genes 0.000 description 7
• 108020000411 Toll-like receptor Proteins 0.000 description 7
• 229940088710 antibiotic agent Drugs 0.000 description 7
• 239000012228 culture supernatant Substances 0.000 description 7
• 239000013604 expression vector Substances 0.000 description 7
• 230000012010 growth Effects 0.000 description 7
• 239000012678 infectious agent Substances 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 230000011664 signaling Effects 0.000 description 7
• MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 6
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
• 101800001224 Disintegrin Proteins 0.000 description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 description 6
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 6
• 230000006907 apoptotic process Effects 0.000 description 6
• MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 6
• 230000003115 biocidal effect Effects 0.000 description 6
• POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 6
• 210000002865 immune cell Anatomy 0.000 description 6
• 238000007912 intraperitoneal administration Methods 0.000 description 6
• 239000012528 membrane Substances 0.000 description 6
• 230000002103 transcriptional effect Effects 0.000 description 6
• 208000035143 Bacterial infection Diseases 0.000 description 5
• 208000037487 Endotoxemia Diseases 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 108091006027 G proteins Proteins 0.000 description 5
• 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 5
• 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 5
• 108010093965 Polymyxin B Proteins 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 230000000845 anti-microbial effect Effects 0.000 description 5
• 208000022362 bacterial infectious disease Diseases 0.000 description 5
• 108060001132 cathelicidin Proteins 0.000 description 5
• 102000014509 cathelicidin Human genes 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 230000003399 chemotactic effect Effects 0.000 description 5
• 238000011109 contamination Methods 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 230000028993 immune response Effects 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 230000003993 interaction Effects 0.000 description 5
• 230000000813 microbial effect Effects 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 229920000024 polymyxin B Polymers 0.000 description 5
• 229960005266 polymyxin b Drugs 0.000 description 5
• 230000007112 pro inflammatory response Effects 0.000 description 5
• 230000010076 replication Effects 0.000 description 5
• 238000003757 reverse transcription PCR Methods 0.000 description 5
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
• 241000589513 Burkholderia cepacia Species 0.000 description 4
• 102000000905 Cadherin Human genes 0.000 description 4
• 108050007957 Cadherin Proteins 0.000 description 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
• 208000035473 Communicable disease Diseases 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• 241000192125 Firmicutes Species 0.000 description 4
• 102000030782 GTP binding Human genes 0.000 description 4
• 108091000058 GTP-Binding Proteins 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 102000043136 MAP kinase family Human genes 0.000 description 4
• 108091054455 MAP kinase family Proteins 0.000 description 4
• 102000005741 Metalloproteases Human genes 0.000 description 4
• 108010006035 Metalloproteases Proteins 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 239000004698 Polyethylene Substances 0.000 description 4
• 206010040070 Septic Shock Diseases 0.000 description 4
• 230000003321 amplification Effects 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 230000033228 biological regulation Effects 0.000 description 4
• 235000018417 cysteine Nutrition 0.000 description 4
• 230000016396 cytokine production Effects 0.000 description 4
• 230000001086 cytosolic effect Effects 0.000 description 4
• 230000007123 defense Effects 0.000 description 4
• 201000010099 disease Diseases 0.000 description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
• 238000004520 electroporation Methods 0.000 description 4
• 239000003623 enhancer Substances 0.000 description 4
• 238000009396 hybridization Methods 0.000 description 4
• 230000006698 induction Effects 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 108020004999 messenger RNA Proteins 0.000 description 4
• 238000002493 microarray Methods 0.000 description 4
• 244000005700 microbiome Species 0.000 description 4
• 230000031990 negative regulation of inflammatory response Effects 0.000 description 4
• 238000003199 nucleic acid amplification method Methods 0.000 description 4
• 239000013612 plasmid Substances 0.000 description 4
• 230000004853 protein function Effects 0.000 description 4
• 230000007115 recruitment Effects 0.000 description 4
• 239000003161 ribonuclease inhibitor Substances 0.000 description 4
• JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 4
• 239000007790 solid phase Substances 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 230000003827 upregulation Effects 0.000 description 4
• 240000005020 Acaciella glauca Species 0.000 description 3
• 102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 3
• 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 3
• 108020004635 Complementary DNA Proteins 0.000 description 3
• OABOXRPGTFRBFZ-IMJSIDKUSA-N Cys-Cys Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(O)=O OABOXRPGTFRBFZ-IMJSIDKUSA-N 0.000 description 3
• 108010002069 Defensins Proteins 0.000 description 3
• 102000000541 Defensins Human genes 0.000 description 3
• AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 3
• 206010014824 Endotoxic shock Diseases 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 3
• 108060006687 MAP kinase kinase kinase Proteins 0.000 description 3
• 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 3
• 241000186359 Mycobacterium Species 0.000 description 3
• 102000015223 NK Cell Lectin-Like Receptors Human genes 0.000 description 3
• 108010039435 NK Cell Lectin-Like Receptors Proteins 0.000 description 3
• 206010028980 Neoplasm Diseases 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 102000035195 Peptidases Human genes 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 230000004721 adaptive immunity Effects 0.000 description 3
• 125000000539 amino acid group Chemical group 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 210000000988 bone and bone Anatomy 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 210000004979 bone marrow derived macrophage Anatomy 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 230000021164 cell adhesion Effects 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000012292 cell migration Effects 0.000 description 3
• 210000002421 cell wall Anatomy 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 108010004073 cysteinylcysteine Proteins 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 238000001514 detection method Methods 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 239000012091 fetal bovine serum Substances 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• 230000002538 fungal effect Effects 0.000 description 3
• 239000011521 glass Substances 0.000 description 3
• 210000003714 granulocyte Anatomy 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• USSYUMHVHQSYNA-SLDJZXPVSA-N indolicidin Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)CC1=CNC2=CC=CC=C12 USSYUMHVHQSYNA-SLDJZXPVSA-N 0.000 description 3
• 210000005007 innate immune system Anatomy 0.000 description 3
• 230000021995 interleukin-8 production Effects 0.000 description 3
• 208000032839 leukemia Diseases 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 239000000203 mixture Substances 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 235000003499 redwood Nutrition 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 238000001356 surgical procedure Methods 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 230000005730 ADP ribosylation Effects 0.000 description 2
• 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 2
• 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 102100035904 Caspase-1 Human genes 0.000 description 2
• 108050004290 Cecropin Proteins 0.000 description 2
• 108091006146 Channels Proteins 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 108010048623 Collagen Receptors Proteins 0.000 description 2
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
• 101800000620 Disintegrin-like Proteins 0.000 description 2
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
• 101000968267 Drosophila melanogaster Protein dachsous Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 2
• 108010066705 H-cadherin Proteins 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
• 101001078133 Homo sapiens Integrin alpha-2 Proteins 0.000 description 2
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
• 102000004157 Hydrolases Human genes 0.000 description 2
• 108090000604 Hydrolases Proteins 0.000 description 2
• 102100025305 Integrin alpha-2 Human genes 0.000 description 2
• 102000000507 Integrin alpha2 Human genes 0.000 description 2
• 108010017642 Integrin alpha2beta1 Proteins 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 102000013691 Interleukin-17 Human genes 0.000 description 2
• 108050003558 Interleukin-17 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 2
• 241000239218 Limulus Species 0.000 description 2
• 102000052508 Lipopolysaccharide-binding protein Human genes 0.000 description 2
• 108010053632 Lipopolysaccharide-binding protein Proteins 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 108060003100 Magainin Proteins 0.000 description 2
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
• 108010002998 NADPH Oxidases Proteins 0.000 description 2
• 102000004722 NADPH Oxidases Human genes 0.000 description 2
• 102100038815 Nocturnin Human genes 0.000 description 2
• 108010029741 Notch4 Receptor Proteins 0.000 description 2
• 108010013639 Peptidoglycan Proteins 0.000 description 2
• 102100022239 Peroxiredoxin-6 Human genes 0.000 description 2
• 101710185569 Peroxiredoxin-6 Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 102100035842 Prostaglandin E2 receptor EP1 subtype Human genes 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 101710172204 Proteasome subunit alpha Proteins 0.000 description 2
• 239000013614 RNA sample Substances 0.000 description 2
• 108091006207 SLC-Transporter Proteins 0.000 description 2
• 102000037054 SLC-Transporter Human genes 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 108010033711 Telomeric Repeat Binding Protein 1 Proteins 0.000 description 2
• 102100036497 Telomeric repeat-binding factor 1 Human genes 0.000 description 2
• 102000009618 Transforming Growth Factors Human genes 0.000 description 2
• 108010009583 Transforming Growth Factors Proteins 0.000 description 2
• 229920004890 Triton X-100 Polymers 0.000 description 2
• 239000013504 Triton X-100 Substances 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
• 239000008186 active pharmaceutical agent Substances 0.000 description 2
• 239000011543 agarose gel Substances 0.000 description 2
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
• RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
• 235000009582 asparagine Nutrition 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 210000000424 bronchial epithelial cell Anatomy 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 229910002091 carbon monoxide Inorganic materials 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 239000002975 chemoattractant Substances 0.000 description 2
• 238000007398 colorimetric assay Methods 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 239000003636 conditioned culture medium Substances 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• 150000001945 cysteines Chemical group 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000008260 defense mechanism Effects 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 231100000284 endotoxic Toxicity 0.000 description 2
• 230000002346 endotoxic effect Effects 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
• 229920000669 heparin Polymers 0.000 description 2
• 229960002897 heparin Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 230000005745 host immune response Effects 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 208000027866 inflammatory disease Diseases 0.000 description 2
• 210000003963 intermediate filament Anatomy 0.000 description 2
• PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 235000005772 leucine Nutrition 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 244000000010 microbial pathogen Species 0.000 description 2
• 238000000329 molecular dynamics simulation Methods 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 229930014626 natural product Natural products 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 238000010606 normalization Methods 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 102000007863 pattern recognition receptors Human genes 0.000 description 2
• 108010089193 pattern recognition receptors Proteins 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 239000004300 potassium benzoate Substances 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 230000002062 proliferating effect Effects 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 229930002330 retinoic acid Natural products 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 210000001550 testis Anatomy 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 229960001727 tretinoin Drugs 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 235000014393 valine Nutrition 0.000 description 2
• 239000013598 vector Substances 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• MEANFMOQMXYMCT-OLZOCXBDSA-M (6R)-5,10-methenyltetrahydrofolate Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2[N+]1=C1)N)N1C1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 MEANFMOQMXYMCT-OLZOCXBDSA-M 0.000 description 1
• MZAGXDHQGXUDDX-JSRXJHBZSA-N (e,2z)-4-ethyl-2-hydroxyimino-5-nitrohex-3-enamide Chemical compound [O-][N+](=O)C(C)C(/CC)=C/C(=N/O)/C(N)=O MZAGXDHQGXUDDX-JSRXJHBZSA-N 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• 102100034487 28S ribosomal protein S18b, mitochondrial Human genes 0.000 description 1
• 102100031928 40S ribosomal protein S29 Human genes 0.000 description 1
• QYNUQALWYRSVHF-ABLWVSNPSA-N 5,10-methylenetetrahydrofolic acid Chemical compound C1N2C=3C(=O)NC(N)=NC=3NCC2CN1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-ABLWVSNPSA-N 0.000 description 1
• 102100028505 6-pyruvoyl tetrahydrobiopterin synthase Human genes 0.000 description 1
• 108010045523 6-pyruvoyltetrahydropterin synthase Proteins 0.000 description 1
• PCFGFYKGPMQDBX-FEKONODYSA-N 78355-50-7 Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 PCFGFYKGPMQDBX-FEKONODYSA-N 0.000 description 1
• 108091022885 ADAM Proteins 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
• 108091093088 Amplicon Proteins 0.000 description 1
• 108010031677 Anaphase-Promoting Complex-Cyclosome Proteins 0.000 description 1
• 102000005446 Anaphase-Promoting Complex-Cyclosome Human genes 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 1
• 101710120040 Antifungal peptide Proteins 0.000 description 1
• 101710145634 Antigen 1 Proteins 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 108020000946 Bacterial DNA Proteins 0.000 description 1
• 102100021971 Bcl-2-interacting killer Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 102100027052 Bone morphogenetic protein receptor type-1B Human genes 0.000 description 1
• 108030001720 Bontoxilysin Proteins 0.000 description 1
• 102100026435 Breast carcinoma-amplified sequence 4 Human genes 0.000 description 1
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
• 108050009406 C-type lectin-like Proteins 0.000 description 1
• 102000002086 C-type lectin-like Human genes 0.000 description 1
• 108010039171 CC cytokine receptor-4 Proteins 0.000 description 1
• 101150019010 CCR3 gene Proteins 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• 102100035680 Cadherin EGF LAG seven-pass G-type receptor 2 Human genes 0.000 description 1
• 102100024155 Cadherin-11 Human genes 0.000 description 1
• 102000014818 Cadherin-13 Human genes 0.000 description 1
• 102100024154 Cadherin-13 Human genes 0.000 description 1
• 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
• 101100042630 Caenorhabditis elegans sin-3 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 208000003643 Callosities Diseases 0.000 description 1
• 102000004041 Caspase 7 Human genes 0.000 description 1
• 108090000567 Caspase 7 Proteins 0.000 description 1
• 108090000426 Caspase-1 Proteins 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 102000016362 Catenins Human genes 0.000 description 1
• 108010067316 Catenins Proteins 0.000 description 1
• 102400001330 Cathepsin H Human genes 0.000 description 1
• 108090000619 Cathepsin H Proteins 0.000 description 1
• 108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
• 102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
• 102100031203 Centrosomal protein 43 Human genes 0.000 description 1
• 108010062745 Chloride Channels Proteins 0.000 description 1
• 102000011045 Chloride Channels Human genes 0.000 description 1
• UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
• 108050001774 Cold shock domains Proteins 0.000 description 1
• 102000010091 Cold shock domains Human genes 0.000 description 1
• 102100031506 Complement C5 Human genes 0.000 description 1
• 108010028773 Complement C5 Proteins 0.000 description 1
• 102400000739 Corticotropin Human genes 0.000 description 1
• 101800000414 Corticotropin Proteins 0.000 description 1
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
• 102100027309 Cyclic AMP-responsive element-binding protein 5 Human genes 0.000 description 1
• 102000016736 Cyclin Human genes 0.000 description 1
• 108050006400 Cyclin Proteins 0.000 description 1
• 108010016777 Cyclin-Dependent Kinase Inhibitor p27 Proteins 0.000 description 1
• 102000000577 Cyclin-Dependent Kinase Inhibitor p27 Human genes 0.000 description 1
• 102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 description 1
• 102100028202 Cytochrome c oxidase subunit 6C Human genes 0.000 description 1
• 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• 102100029905 DNA polymerase epsilon subunit 3 Human genes 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 102000009058 Death Domain Receptors Human genes 0.000 description 1
• 108010049207 Death Domain Receptors Proteins 0.000 description 1
• 108020005199 Dehydrogenases Proteins 0.000 description 1
• 102100039104 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Human genes 0.000 description 1
• 101710178850 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Proteins 0.000 description 1
• 101100042883 Drosophila melanogaster sna gene Proteins 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 102000012737 Electron-Transferring Flavoproteins Human genes 0.000 description 1
• 108010079426 Electron-Transferring Flavoproteins Proteins 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 102100030011 Endoribonuclease Human genes 0.000 description 1
• 101710199605 Endoribonuclease Proteins 0.000 description 1
• 102000013128 Endothelin B Receptor Human genes 0.000 description 1
• 108010090557 Endothelin B Receptor Proteins 0.000 description 1
• 241000194033 Enterococcus Species 0.000 description 1
• 108010062466 Enzyme Precursors Proteins 0.000 description 1
• 102000010911 Enzyme Precursors Human genes 0.000 description 1
• 108090000371 Esterases Proteins 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 102000034286 G proteins Human genes 0.000 description 1
• 102000054184 GADD45 Human genes 0.000 description 1
• 102000002464 Galactosidases Human genes 0.000 description 1
• 108010093031 Galactosidases Proteins 0.000 description 1
• 108010010038 Gamma-protocadherins Proteins 0.000 description 1
• 102100033053 Glutathione peroxidase 3 Human genes 0.000 description 1
• 101710119049 Glutathione peroxidase 3 Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102000010956 Glypican Human genes 0.000 description 1
• 108050001154 Glypican Proteins 0.000 description 1
• 108050007238 Glypican-1 Proteins 0.000 description 1
• 102000006771 Gonadotropins Human genes 0.000 description 1
• 108010086677 Gonadotropins Proteins 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102000008651 Growth factor receptor-bound protein 14 Human genes 0.000 description 1
• 108050000445 Growth factor receptor-bound protein 14 Proteins 0.000 description 1
• 102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 1
• 108091009389 Growth factor receptor-bound protein 2 Proteins 0.000 description 1
• UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Natural products O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
• 108010024164 HLA-G Antigens Proteins 0.000 description 1
• 102000009824 Hepatocyte Nuclear Factor 1-alpha Human genes 0.000 description 1
• 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
• 241000709721 Hepatovirus A Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 101000639839 Homo sapiens 28S ribosomal protein S18b, mitochondrial Proteins 0.000 description 1
• 101000970576 Homo sapiens Bcl-2-interacting killer Proteins 0.000 description 1
• 101000766275 Homo sapiens Breast carcinoma-amplified sequence 4 Proteins 0.000 description 1
• 101000777564 Homo sapiens C-C chemokine receptor type 1 Proteins 0.000 description 1
• 101000946926 Homo sapiens C-C chemokine receptor type 5 Proteins 0.000 description 1
• 101000715674 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 2 Proteins 0.000 description 1
• 101000715398 Homo sapiens Caspase-1 Proteins 0.000 description 1
• 101000776477 Homo sapiens Centrosomal protein 43 Proteins 0.000 description 1
• 101000737958 Homo sapiens Chromatin target of PRMT1 protein Proteins 0.000 description 1
• 101000726193 Homo sapiens Cyclic AMP-responsive element-binding protein 5 Proteins 0.000 description 1
• 101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 1
• 101000861049 Homo sapiens Cytochrome c oxidase subunit 6C Proteins 0.000 description 1
• 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101000864175 Homo sapiens DNA polymerase epsilon subunit 3 Proteins 0.000 description 1
• 101000746364 Homo sapiens Granulocyte colony-stimulating factor receptor Proteins 0.000 description 1
• 101001066158 Homo sapiens Growth arrest and DNA damage-inducible protein GADD45 alpha Proteins 0.000 description 1
• 101001081552 Homo sapiens Inhibitor of Bruton tyrosine kinase Proteins 0.000 description 1
• 101001001420 Homo sapiens Interferon gamma receptor 1 Proteins 0.000 description 1
• 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
• 101000998020 Homo sapiens Keratin, type I cytoskeletal 18 Proteins 0.000 description 1
• 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 1
• 101001139136 Homo sapiens Krueppel-like factor 3 Proteins 0.000 description 1
• 101100020598 Homo sapiens LAPTM4A gene Proteins 0.000 description 1
• 101001020548 Homo sapiens LIM/homeobox protein Lhx1 Proteins 0.000 description 1
• 101000984190 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 1 Proteins 0.000 description 1
• 101000984192 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 3 Proteins 0.000 description 1
• 101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 1
• 101001044093 Homo sapiens Lipopolysaccharide-induced tumor necrosis factor-alpha factor Proteins 0.000 description 1
• 101000942701 Homo sapiens Liprin-alpha-3 Proteins 0.000 description 1
• 101000950648 Homo sapiens Malectin Proteins 0.000 description 1
• 101000645296 Homo sapiens Metalloproteinase inhibitor 2 Proteins 0.000 description 1
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
• 101000884270 Homo sapiens Natural killer cell receptor 2B4 Proteins 0.000 description 1
• 101000918983 Homo sapiens Neutrophil defensin 1 Proteins 0.000 description 1
• 101001117517 Homo sapiens Prostaglandin E2 receptor EP3 subtype Proteins 0.000 description 1
• 101001076724 Homo sapiens RNA-binding protein 28 Proteins 0.000 description 1
• 101000999079 Homo sapiens Radiation-inducible immediate-early gene IEX-1 Proteins 0.000 description 1
• 101001104108 Homo sapiens Rap1 GTPase-activating protein 1 Proteins 0.000 description 1
• 101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 1
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
• 101000866336 Homo sapiens Transcription factor E2F5 Proteins 0.000 description 1
• 101000845269 Homo sapiens Transcription termination factor 1 Proteins 0.000 description 1
• 101000713585 Homo sapiens Tubulin beta-4A chain Proteins 0.000 description 1
• 101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 1
• 101000801232 Homo sapiens Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
• 102100027638 Inhibitor of Bruton tyrosine kinase Human genes 0.000 description 1
• 102100025323 Integrin alpha-1 Human genes 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 108010041341 Integrin alpha1 Proteins 0.000 description 1
• 102000012334 Integrin beta4 Human genes 0.000 description 1
• 108010022238 Integrin beta4 Proteins 0.000 description 1
• 102100020944 Integrin-linked protein kinase Human genes 0.000 description 1
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
• 102000004344 Interferon regulatory factor 2 Human genes 0.000 description 1
• 108090000908 Interferon regulatory factor 2 Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102100039065 Interleukin-1 beta Human genes 0.000 description 1
• 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 description 1
• 101710149731 Interleukin-1 receptor type 2 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102100020792 Interleukin-12 receptor subunit beta-2 Human genes 0.000 description 1
• 101710103840 Interleukin-12 receptor subunit beta-2 Proteins 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102000004557 Interleukin-18 Receptors Human genes 0.000 description 1
• 108010017537 Interleukin-18 Receptors Proteins 0.000 description 1
• 102000006541 Ionotropic Glutamate Receptors Human genes 0.000 description 1
• 108010008812 Ionotropic Glutamate Receptors Proteins 0.000 description 1
• 241000726306 Irus Species 0.000 description 1
• 101150021395 JUND gene Proteins 0.000 description 1
• 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 1
• 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 1
• 102100020678 Krueppel-like factor 3 Human genes 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• 102100031764 LINE-1 retrotransposable element ORF1 protein Human genes 0.000 description 1
• 101710157664 LINE-1 retrotransposable element ORF1 protein Proteins 0.000 description 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
• 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
• 101710142062 Leukemia inhibitory factor receptor Proteins 0.000 description 1
• 102100025584 Leukocyte immunoglobulin-like receptor subfamily B member 1 Human genes 0.000 description 1
• 102100025582 Leukocyte immunoglobulin-like receptor subfamily B member 3 Human genes 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 102100021607 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human genes 0.000 description 1
• 102100032892 Liprin-alpha-3 Human genes 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 102100035304 Lymphotactin Human genes 0.000 description 1
• 102100034728 Lysosomal-associated transmembrane protein 4A Human genes 0.000 description 1
• 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 description 1
• 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 description 1
• 102000025498 MAP Kinase Kinase Kinase 2 Human genes 0.000 description 1
• 108010075656 MAP Kinase Kinase Kinase 2 Proteins 0.000 description 1
• 102100034069 MAP kinase-activated protein kinase 2 Human genes 0.000 description 1
• 108010041955 MAP-kinase-activated kinase 2 Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 101710127797 Macrophage colony-stimulating factor 1 Proteins 0.000 description 1
• 102000004318 Matrilysin Human genes 0.000 description 1
• 108090000855 Matrilysin Proteins 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 108010036176 Melitten Proteins 0.000 description 1
• 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 description 1
• 102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
• 108700027648 Mitogen-Activated Protein Kinase 8 Proteins 0.000 description 1
• 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
• 102100030173 Muellerian-inhibiting factor Human genes 0.000 description 1
• 101100421767 Mus musculus Snai1 gene Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 102000003505 Myosin Human genes 0.000 description 1
• 108060008487 Myosin Proteins 0.000 description 1
• 102000019148 NF-kappaB-inducing kinase activity proteins Human genes 0.000 description 1
• 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 description 1
• 101800000287 Neutrophil defensin 2 Proteins 0.000 description 1
• 102400001060 Neutrophil defensin 2 Human genes 0.000 description 1
• 101001123254 Nicotiana tabacum Protoporphyrinogen oxidase, chloroplastic Proteins 0.000 description 1
• 102000001753 Notch4 Receptor Human genes 0.000 description 1
• 102100021858 Nuclear receptor-binding protein Human genes 0.000 description 1
• 101710127265 Nuclear receptor-binding protein Proteins 0.000 description 1
• 102000012547 Olfactory receptors Human genes 0.000 description 1
• 108050002069 Olfactory receptors Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 102000004140 Oncostatin M Human genes 0.000 description 1
• 108090000630 Oncostatin M Proteins 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 102000016978 Orphan receptors Human genes 0.000 description 1
• 108070000031 Orphan receptors Proteins 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 101710190786 PI protein Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010034133 Pathogen resistance Diseases 0.000 description 1
• 108010044843 Peptide Initiation Factors Proteins 0.000 description 1
• 102000005877 Peptide Initiation Factors Human genes 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 101710097690 Prostaglandin E2 receptor EP1 subtype Proteins 0.000 description 1
• 102100024447 Prostaglandin E2 receptor EP3 subtype Human genes 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 101710096541 Proteasome subunit beta Proteins 0.000 description 1
• 101710094499 Proteasome subunit beta type-4 Proteins 0.000 description 1
• 101710094473 Proteasome subunit beta type-7 Proteins 0.000 description 1
• 102100035763 Proteasome subunit beta type-7 Human genes 0.000 description 1
• 101710095664 Protein 6.3 Proteins 0.000 description 1
• 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102100023087 Protein S100-A4 Human genes 0.000 description 1
• 108010001648 Proto-Oncogene Proteins c-ret Proteins 0.000 description 1
• 102000000813 Proto-Oncogene Proteins c-ret Human genes 0.000 description 1
• 240000004350 Prunus spinosa Species 0.000 description 1
• 235000010829 Prunus spinosa Nutrition 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 102100020834 RCC1 and BTB domain-containing protein 2 Human genes 0.000 description 1
• 101710186923 RCC1 and BTB domain-containing protein 2 Proteins 0.000 description 1
• 108020004518 RNA Probes Proteins 0.000 description 1
• 239000003391 RNA probe Substances 0.000 description 1
• 102100025872 RNA-binding protein 28 Human genes 0.000 description 1
• 102100036900 Radiation-inducible immediate-early gene IEX-1 Human genes 0.000 description 1
• 102100040088 Rap1 GTPase-activating protein 1 Human genes 0.000 description 1
• 101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
• 229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
• 102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 102000002278 Ribosomal Proteins Human genes 0.000 description 1
• 108010000605 Ribosomal Proteins Proteins 0.000 description 1
• 108010085149 S100 Calcium-Binding Protein A4 Proteins 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 229920005654 Sephadex Polymers 0.000 description 1
• 239000012507 Sephadex™ Substances 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 108010022999 Serine Proteases Proteins 0.000 description 1
• 102000012479 Serine Proteases Human genes 0.000 description 1
• 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 108010052164 Sodium Channels Proteins 0.000 description 1
• 102000018674 Sodium Channels Human genes 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 108700017375 Specific Granule Deficiency Proteins 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 206010041925 Staphylococcal infections Diseases 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 101100335596 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) ftsY gene Proteins 0.000 description 1
• 102000006467 TATA-Box Binding Protein Human genes 0.000 description 1
• 108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
• 101710159236 TGFB1-induced anti-apoptotic factor 1 Proteins 0.000 description 1
• 102100033077 TNF receptor-associated factor 2 Human genes 0.000 description 1
• 108090000925 TNF receptor-associated factor 2 Proteins 0.000 description 1
• 102100033082 TNF receptor-associated factor 3 Human genes 0.000 description 1
• 108090000922 TNF receptor-associated factor 3 Proteins 0.000 description 1
• 102100036494 Testisin Human genes 0.000 description 1
• 108050003829 Testisin Proteins 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
• 108010031429 Tissue Inhibitor of Metalloproteinase-3 Proteins 0.000 description 1
• 102100027010 Toll-like receptor 1 Human genes 0.000 description 1
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
• 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
• 102000011409 Transcobalamins Human genes 0.000 description 1
• 108010023603 Transcobalamins Proteins 0.000 description 1
• 102100031632 Transcription factor E2F5 Human genes 0.000 description 1
• 241000984695 Troglodytinae Species 0.000 description 1
• 102100036788 Tubulin beta-4A chain Human genes 0.000 description 1
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 1
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
• 206010054094 Tumour necrosis Diseases 0.000 description 1
• 102000014384 Type C Phospholipases Human genes 0.000 description 1
• 108010079194 Type C Phospholipases Proteins 0.000 description 1
• 108010051765 Type I Bone Morphogenetic Protein Receptors Proteins 0.000 description 1
• 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
• 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
• LFTYTUAZOPRMMI-NESSUJCYSA-N UDP-N-acetyl-alpha-D-galactosamine Chemical compound O1[C@H](CO)[C@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-NESSUJCYSA-N 0.000 description 1
• LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102400000757 Ubiquitin Human genes 0.000 description 1
• 102000003431 Ubiquitin-Conjugating Enzyme Human genes 0.000 description 1
• 108060008747 Ubiquitin-Conjugating Enzyme Proteins 0.000 description 1
• 102100038932 Unconventional myosin-XVIIIa Human genes 0.000 description 1
• 108010059993 Vancomycin Proteins 0.000 description 1
• 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 1
• 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 101100421768 Xenopus laevis snai1 gene Proteins 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 238000004847 absorption spectroscopy Methods 0.000 description 1
• 229940100228 acetyl coenzyme a Drugs 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 210000005006 adaptive immune system Anatomy 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
• LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 230000003042 antagnostic effect Effects 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 239000000868 anti-mullerian hormone Substances 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 238000011203 antimicrobial therapy Methods 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 150000001483 arginine derivatives Chemical class 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• RHISNKCGUDDGEG-UHFFFAOYSA-N bactenecin Chemical compound CCC(C)C1NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)C(CCCN=C(N)N)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(N)CCCN=C(N)N)CSSCC(C(=O)NC(CCCN=C(N)N)C(O)=O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC1=O RHISNKCGUDDGEG-UHFFFAOYSA-N 0.000 description 1
• 108010016341 bactenecin Proteins 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 238000004820 blood count Methods 0.000 description 1
• 229940112869 bone morphogenetic protein Drugs 0.000 description 1
• 229940053031 botulinum toxin Drugs 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 108010007004 cathelin Proteins 0.000 description 1
• 101150059448 cdk7 gene Proteins 0.000 description 1
• 230000008568 cell cell communication Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
• 230000004186 co-expression Effects 0.000 description 1
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
• 239000005516 coenzyme A Substances 0.000 description 1
• 229940093530 coenzyme a Drugs 0.000 description 1
• 230000002281 colonystimulating effect Effects 0.000 description 1
• 229920001577 copolymer Chemical compound 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
• 229960000258 corticotropin Drugs 0.000 description 1
• 239000013058 crude material Substances 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 238000010217 densitometric analysis Methods 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
• 238000000586 desensitisation Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 229910003460 diamond Inorganic materials 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• 230000002222 downregulating effect Effects 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 230000009762 endothelial cell differentiation Effects 0.000 description 1
• 108010072542 endotoxin binding proteins Proteins 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 230000003203 everyday effect Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 239000002622 gonadotropin Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 102000017941 granulin Human genes 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• XGFJCRNRWOXGQM-UHFFFAOYSA-N hot-2 Chemical compound CCSC1=CC(OC)=C(CCNO)C=C1OC XGFJCRNRWOXGQM-UHFFFAOYSA-N 0.000 description 1
• 102000018474 human neutrophil peptide 1 Human genes 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 229940088592 immunologic factor Drugs 0.000 description 1
• 239000000367 immunologic factor Substances 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 230000003960 inflammatory cascade Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 108091006086 inhibitor proteins Proteins 0.000 description 1
• 238000013383 initial experiment Methods 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 230000002608 insulinlike Effects 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 108010059517 integrin-linked kinase Proteins 0.000 description 1
• 230000005732 intercellular adhesion Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 235000014705 isoleucine Nutrition 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 108010019677 lymphotactin Proteins 0.000 description 1
• 108091005446 macrophage receptors Proteins 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
• 210000003071 memory t lymphocyte Anatomy 0.000 description 1
• 239000001369 metatartaric acid Substances 0.000 description 1
• 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
• UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
• 150000004702 methyl esters Chemical group 0.000 description 1
• 229960003085 meticillin Drugs 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004899 motility Effects 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• YIEDSISPYKQADU-UHFFFAOYSA-N n-acetyl-n-[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]acetamide Chemical compound C1=C(C)C(N(C(C)=O)C(=O)C)=CC=C1N=NC1=CC=CC=C1C YIEDSISPYKQADU-UHFFFAOYSA-N 0.000 description 1
• 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• GRZXCHIIZXMEPJ-HTLKCAKFSA-N neutrophil peptide-2 Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=4C=CC(O)=CC=4)NC(=O)[C@@H](N)CSSC[C@H](NC2=O)C(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](C)C(=O)N3)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](C)C(=O)N1)[C@@H](C)CC)[C@@H](C)O)=O)[C@@H](C)CC)C1=CC=CC=C1 GRZXCHIIZXMEPJ-HTLKCAKFSA-N 0.000 description 1
• 239000002547 new drug Substances 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 231100000956 nontoxicity Toxicity 0.000 description 1
• 239000000346 nonvolatile oil Substances 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 150000002894 organic compounds Chemical class 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 108010000953 osteoblast cadherin Proteins 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• 108010069653 peptide E (adrenal medulla) Proteins 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 150000002978 peroxides Chemical class 0.000 description 1
• 210000001539 phagocyte Anatomy 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 231100000683 possible toxicity Toxicity 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000007126 proinflammatory cytokine response Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 108020003519 protein disulfide isomerase Proteins 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 108010008366 protein phosphatase 6 Proteins 0.000 description 1
• 230000004844 protein turnover Effects 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 229910052761 rare earth metal Inorganic materials 0.000 description 1
• 108700042226 ras Genes Proteins 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108010093173 ribosomal protein S29 Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 101150015999 sec24 gene Proteins 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 208000013223 septicemia Diseases 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 208000000162 specific granule deficiency Diseases 0.000 description 1
• 229940063673 spermidine Drugs 0.000 description 1
• 229940063675 spermine Drugs 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 238000004809 thin layer chromatography Methods 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 210000003371 toe Anatomy 0.000 description 1
• 230000002463 transducing effect Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
• 229960003165 vancomycin Drugs 0.000 description 1
• MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 210000005167 vascular cell Anatomy 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 210000004340 zona pellucida Anatomy 0.000 description 1
• KRJOFJHOZZPBKI-KSWODRSDSA-N α-defensin-1 Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=4C=CC(O)=CC=4)NC(=O)[C@H](CSSC[C@H](NC2=O)C(O)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](C)C(=O)N3)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](C)C(=O)N1)[C@@H](C)CC)[C@@H](C)O)=O)[C@@H](C)CC)C1=CC=CC=C1 KRJOFJHOZZPBKI-KSWODRSDSA-N 0.000 description 1